drugset / Trial / NCT02242799
Dolutegravir Interactions With Artemisinin-based Combination Therapies
Phase 1
Completed
46 enrolled
University of Liverpool
Makerere University · collabViiV Healthcare · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Malaria and HIV are found in the same regions of the world and developing countries are most affected by both diseases. For malaria, new drugs have been introduced called ACTs. These drugs are effective against malaria but little is known about how the levels of these drugs in blood relate to how effective these drugs are. For HIV, a new drug has been developed called dolutegravir which has potential to be widely used in developing countries. This proposal will explore how dolutegravir affects the drug levels of these antimalarial drugs and vice versa. In total, 46 healthy volunteers will participate in this study.
Timeline
- Start
- 2015-06
- Primary completion
- 2016-09
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Artemether | Small molecule | — | — |
| Subject | Artesunate | Small molecule | — | — |
| Subject | Dolutegravir | Other / unclassified | 50 mg | — |
| Subject | amodiaquine | Other / unclassified | — | — |
| Subject | lumefantrine | Small molecule | — | — |